Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Robotech strategy - June 2021

  • 06 July 2021 (5 min read)

The prospect of vaccinations should allow the robotic surgery market to return to more normal levels later in 2021

  • Value stocks have been weaker than growth orientated sectors in June
  • We saw strong returns from our healthcare and semiconductors companies
  • We increased our weights in several of our Japanese automation holdings

What’s happening?

Equity markets rose in June 2021 (MSCI ACWI Index in USD terms), after a few months of outperformance value stocks have been weaker than growth orientated sectors over the period. This regain of appetite towards growth names was driven by the Fed1 's message to prevent the economy from overheating which could imply an earlier but more moderate pace of rate rises. This backdrop has been more favourable for the Robotech strategy over June given its positioning in various secular growth themes.

The roll out of COVID-19 vaccines continued during the month with a number of US states and several countries in Europe gradually lifting restrictions, giving hopes for a normalisation of economic activity. We continue to see encouraging prospects for a global economic recovery, 2021 growth forecasts having been revised upward for most regions. Activity indicators such as PMIs2  are continuing to show solid improvements. Leading indicators for Japanese industrial activity, such as Machine tool orders and Robot orders continue to show a robust global recovery, which should be supportive of demand for a range of automation equipment providers.

The market continued to focus on the prospect of inflation, but Federal Reserve Chairman Jerome Powell reiterated his views that recent inflation spike is likely to be temporary. Investors will closely watch possible signs of inflation and labour shortage in job reports over the coming weeks as a number of states are ending extended unemployment benefits.

Portfolio positioning and performance

During June, we saw strong returns from our healthcare companies. We saw strong performance from Dexcom, a leading manufacturer of continuous glucose monitoring devices for diabetic patients, as the company is broadening the case for its device to be used by more patients, including the ones suffering from Type 2 diabetes. We also saw strength in Intuitive Surgical, the leader in robotic Surgery who is more exposed to elective surgical procedures.  Elective procedures in 2020 have, in some cases, been postponed due to COVID as other patients were prioritised in hospitals. The prospect of vaccinations should allow this market to return to more normal levels later in 2021, with patients that should have been treated in 2020, likely to be able to have these procedures once we see some stability.

Our semiconductors holdings performed strongly, the sector benefitted from the broader rotation into growth names after a few months of muted performance; we saw particular strength from companies who specialise in High Performance Computing and Artificial Intelligence such as Nvidia and AMD.

In June, we added Align Technology to the portfolio, who manufactures clear aligners used in orthodontics and 3D digital scanners. The company is disrupting the orthodontic industry with its digital approach to dental procedures, using additive manufacturing to produce custom aligners and should continue to gain market share from traditional braces.

We increased our weights in several of our Japanese automation holdings, as Japan has underperformed global markets year to date, driven by a slower vaccine roll out, however outlooks for automation businesses appear strong with demand improving and companies having a more international focus: we added to SMC, a leading supplier of motion control equipment, Japanese robotics manufacturer Fanuc, sensor and vision systems manufacturer Keyence and Nabtesco, supplier of reduction gears for robotic motion control. We also added to Siemens, German industrial conglomerate, as the business outlook across many business lines is improving.

We took some profits from our holdings in Nvidia and Alphabet after a period of strong performance.


Signs of a rebound in industrial activity and strong order books for industrial robotics companies bode well for a recovery in 2021 post the COVID-19 disruptions.  At present, this is particularly apparent in terms of Chinese activity, with the US recovering too, whilst Europe and Japan are a little further behind.

In addition to the pent up demand for automation equipment post COVID-19, we believe that there are also elements of pent up demand coming thorough post the US China trade war of 2019/2020 – we were starting to see signs of this recovery at the end of 2019 and early 2020 before COVID put companies investment plans on hold.  If this does start to materialise, this could signal a more prolonged period of higher industrial activity and CAPEX3  investments, supportive to a range of automation companies.

Ecommerce has seen volumes rise significantly during the lockdowns and companies with a strong online presence have benefitted whereas companies that have been slower to adopt ecommerce have often struggled.  Whilst some of this current shift to ecommerce is temporary, we do believe that some spending habits will be permanently altered.  To support this shift towards ecommerce going forward, we anticipate major spending for logistics and fulfilment centres as companies need to reinforce their capabilities in this area. This increase in CAPEX3  will likely be beneficial to a wide range of automation suppliers.

It is increasingly recognised that Electric Vehicles (EVs) are starting to get more interest from consumers as the costs of the vehicles come down, battery technology improves, and consumers focus on environmental trends.  What is perhaps less focussed on is the significant investment that is needed to manufacture these new EVs and their batteries.  It is important to note that CAPEX3  decisions are being made currently for vehicles that will be produced in 12-24 months’ time, so the prospects for companies supplying equipment such as industrial robots, lasers and vison systems is improving.

No assurance can be given that the Robotech Strategy will be successful. Investors can lose some or all of their capital invested. The Robotech strategy is subject to risks including; Equity; Emerging markets; Investments in specific sectors or asset classes; Global investments; Investments in small and/or micro capitalisation universe; ESG.

  • RmVkOiBGZWRlcmFsIFJlc2VydmU=
  • UE1JOiBQdXJjaGFzaW5nIE1hbmFnZXJzJyBJbmRleA==
  • Q0FQRVg6IENhcGl0YWwgRXhwZW5kaXR1cmU=
  • Q0FQRVg6IENhcGl0YWwgRXhwZW5kaXR1cmU=
  • Q0FQRVg6IENhcGl0YWwgRXhwZW5kaXR1cmU=
Download the full article
Download article (257.13 KB)
Evolving Economy

What is automation?

Investing in automation and robotics - How are companies capitalising on robotics – and what does this mean for investors?

Find out more

Visit the fund center

AXA WF Framlington Robotech

The Sub-Fund seeks to provide long-term capital growth, measured in USD, from a portfolio of listed equity and equity related securities.

View funds

Related Articles


Robotics sector looks primed for further growth in 2024


Taking stock of 2023: Tech Update

  • by AXA Investment Managers
  • 21 December 2023 (5 min read)

Global Thematics strategy - February 2023

  • by David Shaw, Mark Hargraves
  • 21 February 2023 (5 min read)

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment.  Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. The strategies discussed in this document may not be available in your jurisdiction.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.